| Identification | Back Directory | [Name]
(R)-N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-2-hydroxypropyl)-4-(trifluoromethoxy)benzenesulfonamide | [CAS]
1423077-95-5 | [Synonyms]
RTC-30
EOS-61245
(R)-N-(3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-2-hydroxypropyl)-4-(trifluoromethoxy)benzenesulfonamide
Benzenesulfonamide, N-[(2R)-3-(10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)-2-hydroxypropyl]-4-(trifluoromethoxy)- | [Molecular Formula]
C24H23F3N2O4S | [MDL Number]
MFCD32201070 | [MOL File]
1423077-95-5.mol | [Molecular Weight]
492.51 |
| Hazard Information | Back Directory | [Uses]
RTC-30 is an optimized phenothiazine with anti-cancer potency. RTC-30 contains a hydroxylated linker (N) that confers increased oral bioavailability[1]. | [References]
[1] Kastrinsky DB, et al. Reengineered tricyclic anti-cancer agents. Bioorg Med Chem. 2015 Oct 1;23(19):6528-34. DOI:10.1016/j.bmc.2015.07.007 |
|
|